These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 18064333)

  • 1. Randomised comparison of G-CSF-mobilized peripheral blood mononuclear cells versus bone marrow-mononuclear cells for the treatment of patients with lower limb arteriosclerosis obliterans.
    Huang PP; Yang XF; Li SZ; Wen JC; Zhang Y; Han ZC
    Thromb Haemost; 2007 Dec; 98(6):1335-42. PubMed ID: 18064333
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Granulocyte colony-stimulating factor improves the efficacy of autologous bone marrow-derived mononuclear cell transplantation treatment for lower limb ischemia.
    Gu Y; Guo L; Guo J; Dardik A; Zhang S; Tong Z; Zhang J; Wang Z
    Int Angiol; 2017 Aug; 36(4):346-353. PubMed ID: 27958690
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of autologous bone marrow mononuclear cell implantation therapy as a limb salvage procedure in patients with severe peripheral arterial disease.
    Franz RW; Parks A; Shah KJ; Hankins T; Hartman JF; Wright ML
    J Vasc Surg; 2009 Dec; 50(6):1378-90. PubMed ID: 19837539
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Safety and efficacy of granulocyte-colony-stimulating factor administration following autologous intramuscular implantation of bone marrow mononuclear cells: a randomized controlled trial in patients with advanced lower limb ischemia.
    Zafarghandi MR; Ravari H; Aghdami N; Namiri M; Moazzami K; Taghiabadi E; Fazel A; Pournasr B; Farrokhi A; Sharifian RA; Salimi J; Moini M; Baharvand H
    Cytotherapy; 2010 Oct; 12(6):783-91. PubMed ID: 20078390
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combination of autologous transplantation of G-CSF-mobilized peripheral blood mononuclear cells and Panax notoginseng saponins in the treatment of unreconstructable critical limb ischemia.
    Wang X; Jiang L; Wang X; Yin F; Li G; Feng X; Wang K; Sun S
    Ann Vasc Surg; 2014 Aug; 28(6):1501-12. PubMed ID: 24632316
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adverse events during treatment of critical limb ischemia with autologous peripheral blood mononuclear cell implant.
    Jonsson TB; Larzon T; Arfvidsson B; Tidefelt U; Axelsson CG; Jurstrand M; Norgren L
    Int Angiol; 2012 Feb; 31(1):77-84. PubMed ID: 22330628
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Autologous cells derived from different sources and administered using different regimens for 'no-option' critical lower limb ischaemia patients.
    Abdul Wahid SF; Ismail NA; Wan Jamaludin WF; Muhamad NA; Abdul Hamid MKA; Harunarashid H; Lai NM
    Cochrane Database Syst Rev; 2018 Aug; 8(8):CD010747. PubMed ID: 30155883
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bone marrow mononuclear cells versus G-CSF-mobilized peripheral blood mononuclear cells for treatment of lower limb ASO: pooled analysis for long-term prognosis.
    Onodera R; Teramukai S; Tanaka S; Kojima S; Horie T; Matoba S; Murohara T; Matsubara H; Fukushima M; ;
    Bone Marrow Transplant; 2011 Feb; 46(2):278-84. PubMed ID: 20479708
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Comparative study on autologous implantation between bone marrow stem cells and peripheral blood stem cells for treatment of lower limb ischemia].
    Gu Y; Zhang J; Qi L
    Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2007 Jul; 21(7):675-8. PubMed ID: 17694651
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intramuscular or combined intramuscular/intra-arterial administration of bone marrow mononuclear cells: a clinical trial in patients with advanced limb ischemia.
    Van Tongeren RB; Hamming JF; Fibbe WE; Van Weel V; Frerichs SJ; Stiggelbout AM; Van Bockel JH; Lindeman JH
    J Cardiovasc Surg (Torino); 2008 Feb; 49(1):51-8. PubMed ID: 18212687
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Outcome From a Randomized Controlled Clinical Trial　- Improvement of Peripheral Arterial Disease by Granulocyte Colony-Stimulating Factor-Mobilized Autologous Peripheral-Blood-Mononuclear Cell Transplantation (IMPACT).
    Horie T; Yamazaki S; Hanada S; Kobayashi S; Tsukamoto T; Haruna T; Sakaguchi K; Sakai K; Obara H; Morishita K; Saigo K; Shintani Y; Kubo K; Hoshino J; Oda T; Kaneko E; Nishikido M; Ioji T; Kaneda H; Fukushima M;
    Circ J; 2018 Jul; 82(8):2165-2174. PubMed ID: 29877199
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of implanted bone marrow progenitor cell composition on limb salvage after cell implantation in patients with critical limb ischemia.
    Iso Y; Soda T; Sato T; Sato R; Kusuyama T; Omori Y; Shoji M; Koba S; Katagiri T; Kobayashi Y; Suzuki H
    Atherosclerosis; 2010 Mar; 209(1):167-72. PubMed ID: 19748620
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Limb salvage using intramuscular injection of unfractionated autologous bone marrow mononuclear cells in critical limb ischemia: a prospective pilot clinical trial.
    Gabr H; Hedayet A; Imam U; Nasser M
    Exp Clin Transplant; 2011 Jun; 9(3):197-202. PubMed ID: 21649569
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term clinical outcomes for patients with lower limb ischemia implanted with G-CSF-mobilized autologous peripheral blood mononuclear cells.
    Horie T; Onodera R; Akamastu M; Ichikawa Y; Hoshino J; Kaneko E; Iwashita C; Ishida A; Tsukamoto T; Teramukai S; Fukushima M; Kawamura A;
    Atherosclerosis; 2010 Feb; 208(2):461-6. PubMed ID: 19720375
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [A clinical study on implantation of autologous bone marrow mononuclear cells after bone marrow stimulation for treatment of lower limb ischemia].
    Gu Y; Zhang J; Qi L
    Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2006 Oct; 20(10):1017-20. PubMed ID: 17140078
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [A FOLLOW-UP STUDY ON AUTOLOGOUS BONE MARROW MONONUCLEAR CELLS TRANSPLANTATION FOR CRITICAL LOWER ARTERIOSCLEROSIS OBLITERANS IN DIABETIC PATIENTS].
    Dou Y; Zhao J; Zhang L; Wang X; Yuan H; Yuan C
    Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2015 Jul; 29(7):893-8. PubMed ID: 26540987
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transplantation of purified CD34+ cells in the treatment of critical limb ischemia.
    Dong Z; Chen B; Fu W; Wang Y; Guo D; Wei Z; Xu X; Mendelsohn FO
    J Vasc Surg; 2013 Aug; 58(2):404-411.e3. PubMed ID: 23611711
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Autologous bone-marrow mononuclear cell implantation reduces long-term major amputation risk in patients with critical limb ischemia: a comparison of atherosclerotic peripheral arterial disease and Buerger disease.
    Idei N; Soga J; Hata T; Fujii Y; Fujimura N; Mikami S; Maruhashi T; Nishioka K; Hidaka T; Kihara Y; Chowdhury M; Noma K; Taguchi A; Chayama K; Sueda T; Higashi Y
    Circ Cardiovasc Interv; 2011 Feb; 4(1):15-25. PubMed ID: 21205941
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Local intramuscular transplantation of autologous mononuclear cells for critical lower limb ischaemia.
    Moazzami K; Moazzami B; Roohi A; Nedjat S; Dolmatova E
    Cochrane Database Syst Rev; 2014 Dec; 2014(12):CD008347. PubMed ID: 25525690
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy and Safety of Autologous Cell-based Therapy in Patients with No-option Critical Limb Ischaemia: A Meta-Analysis.
    Wahid FSA; Ismail NA; Wan Jamaludin WF; Muhamad NA; Mohamad Idris MA; Lai NM
    Curr Stem Cell Res Ther; 2018; 13(4):265-283. PubMed ID: 29532760
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.